Keyt Bruce 4
4 · IGM Biosciences, Inc. · Filed Apr 20, 2023
Insider Transaction Report
Form 4
Keyt Bruce
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-04-18+21,126→ 138,080 total
Holdings
- 1,013(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]These securities are restricted stock units (RSUs), granted pursuant to the election by the Reporting Person to receive RSUs in lieu of an earned cash bonus for performance in fiscal year 2022. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2023, provided that the Reporting Person remains a service provider through the vesting date.
- [F2]The shares are held directly by the Reporting Person's spouse.